Search results
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 1 day agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies ...
A Guide to Managing Covid This Summer
New York Times· 4 days agoKP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers for Disease Control and Prevention shows a small increase...
House Republicans’ Attempts to Attack Fauci Go Wildly Off Rails
The New Republic via Yahoo News· 4 days ago“No—I’m on the record, and I want to make sure that this is clear: that I developed a monoclonal ...
Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'
Rolling Stone· 4 days agoAnthony Fauci over his involvement in the response to the Covid-19 pandemic. Fauci was summoned...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 7 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of ...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 day agoThe RSV market has altered substantially in recent years owing to the emergence of novel vaccines...
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
Anti-CD20 HGG Linked to Serious Infection Risk in MS
Medscape· 7 hours agoHypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and risk factors in multiple...
On a congressional COVID hearing, and weaponized uncertainty
Columbia Journalism Review· 1 day agoAs the virus continued to spread, so did various versions of the theory. In February 2021, Facebook finally announced that it would remove any posts suggesting that the COVID
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 7 hours agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.